Generic dossier
Clindamycin + benzoyl peroxide
Benzoyl peroxide 2.5/3.75/5%, clindamycin phosphate 1.2/1.0% · Topical gel · Acne vulgaris
Product data
- Strength
- Benzoyl peroxide 2.5/3.75/5%, clindamycin phosphate 1.2/1.0%
- Dosage form
- Topical gel
- Dosage-form group
- Topical
- Therapeutic area
- Acne vulgaris
- Market
- EU/US
- Status
- Dossier target · Jul 2027
- Development status
- Charged for stability
- Portfolio
- Generic dossier
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23